0000921895-22-002497.txt : 20220818 0000921895-22-002497.hdr.sgml : 20220818 20220818161912 ACCESSION NUMBER: 0000921895-22-002497 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220817 FILED AS OF DATE: 20220818 DATE AS OF CHANGE: 20220818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Green James W CENTRAL INDEX KEY: 0001400121 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33957 FILM NUMBER: 221177700 MAIL ADDRESS: STREET 1: 12525 CHADRON AVENUE CITY: HAWTHORNE STATE: CA ZIP: 90250 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC CENTRAL INDEX KEY: 0001123494 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043306140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL RD CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: 5088938999 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746 4 1 form412799001_08182022.xml OWNERSHIP DOCUMENT X0306 4 2022-08-17 0 0001123494 HARVARD BIOSCIENCE INC HBIO 0001400121 Green James W C/O HARVARD BIOSCIENCE, INC. 84 OCTOBER HILL ROAD HOLLISTON MA 01746 1 1 0 0 Chief Executive Officer Common Stock 2022-08-17 4 P 0 40000 3.19 A 2248811 D This transaction was executed in multiple trades at prices ranging from $3.14 to $3.23, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Includes (a) the shares described in footnote (1) above, (b) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (c) 109,071 remaining restricted stock units that will vest on June 11, 2023, (d) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (e) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (f) 104,590 remaining restricted stock units that will vest on January 1, 2023, (g) 332,039 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (h) 1,267,205 shares of common stock beneficially owned by the Reporting Person. /s/ Michael A. Rossi, by power of attorney 2022-08-18